Navigation Links
Cancer Experts Detail Advanced Radiosurgery Treatments for Lung Cancer Using Varian Medical Systems Technologies
Date:4/22/2013

four minutes."

Dr. Parag Parikh , assistant professor of radiation oncology at Washington University in St. Louis, U.S., detailed the results of an ongoing clinical trial using Calypso Anchored Beacon® transponders in lung cancer patients.²   The trial is primarily intended to evaluate tumor localization with the Calypso system for patients with implanted anchored transponders and to assess the positional stability of the transponders throughout the treatment process. "The data we have gathered so far shows that the implantation is safe and that there is very little migration of the markers," said Dr. Parikh.

The Varian symposium was chaired by Dr. Marta Scorsetti , director of radiotherapy and radiosurgery at the Humanitas Cancer Center in Milan, Italy, where more than 300 lung cancer patients have been treated using a TrueBeam treatment machine since its installation in July 2010.

The symposium commenced with Professor Philippe Lambin , head of radiation oncology at the MAASTRO Clinic in Maastricht, the Netherlands, outlining the need for software-based 'Decision Support Systems' (DSS) to allow individualized treatments.

Such systems, he said, are particularly valuable because of the huge volume of information that the modern clinician needs to assess. "With the help of DSS, doctors are able to more objectively select the best individualized treatment," said Prof. Lambin. "By utilizing a system which not only integrates all diagnostic information and therapeutic options but also takes into account the wishes of the patient, it's easier for medical professionals to propose tailor-made treatment plans to patients."    

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California
'/>"/>

SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy Adds The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
2. Heritage-DREAM, National Cancer Institute Breast Cancer Network Inference Prize Announced
3. Cancer Network Features Coverage of Financial Toxicity
4. Premier Prostate Cancer Center the Latest Center to Achieve High Honor of ACR Accreditation
5. Free Skin Cancer Screenings May 4th Precede Melanoma Monday in 14 Cities
6. MD Anderson Cancer Center Acquires Two Elekta Versa HD Systems
7. 2013 Cancer Diagnostics Market Analysis: Cancer Testing Industry Growing Rapidly
8. Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013
9. Debiopharm Group to Support Ascepion in the Development of Debio 1144 for the Treatment of Chinese Cancer Patients
10. Une nouvelle immunothérapie anticancéreuse sur le point dentrer en phase dessais cliniques
11. Se prepara para entrar en ensayos clínicos una nueva inmunoterapia contra el cáncer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 Decision Resources Group finds that over ... Food and Drug Administration,s (FDA) approval of Vifor Fresenius ... was approved by the FDA in November 2013 for ... patients on dialysis. Other key findings from ... 2014 : , ...
(Date:1/15/2014)... Most osteoporosis patients want a choice in the medication ... by Mission Pharmacal Company. The survey, conducted by ... community, revealed that 74 percent of osteoporosis patients surveyed ... other than a pill or a tablet. ...
(Date:1/15/2014)... today announced it has established a relief fund ... that has gripped much of the nation. AARP and its ... support these emergency relief efforts AARP and AARP Foundation will ... to $500,000 in aid. The matching program will be administered ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
... DUSA Pharmaceuticals, Inc.® (Nasdaq: DUSA ), a ... it has been named to Deloitte,s 2010 Technology Fast ... DUSA as one of the Top 500 fastest growing ... in North America.  Rankings are based on percentage of ...
... Oct. 26 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... Officer of Neurocrine Biosciences, will be presenting at the Oppenheimer ... The live presentation takes place on Tuesday, November 2, ... Time.  The presentation will be webcast and may be accessed ...
Cached Medicine Technology:DUSA Pharmaceuticals Named to Deloitte's 2010 Technology Fast 500 List of Fastest Growing Companies in North America 2
(Date:7/10/2014)... Teens who are sensitive to light or noise after ... such as anxiety and depression, a new study says. ... issues teens experience after concussion may help in planning ... when to return to play and what accommodations are ... Koehl and Dong Han, of the University of Kentucky ...
(Date:7/10/2014)... Dennis Thompson HealthDay ... About six out of 10 adults make use of calorie ... order in restaurants, according to a new U.S. study. ... lead author, Seung Hee Lee-Kwan, an epidemiologist with the U.S. ... women surveyed said they used menu labeling to help choose ...
(Date:7/10/2014)... with a microchip-based device developed at the Massachusetts General ... MGH Cancer Center can be cultured to establish cell ... the July 11 issue of Science , an ... reflect a tumor,s genetic mutation over time and changing ... culture cells from the blood that represent those present ...
(Date:7/10/2014)... The U.S. Department of Health and Human Services ... (UH) Case Medical Center Seidman Cancer Center totaling $4.7 ... improving care for patients with complex cancer. , ... unique model developed at UH to enhance care for ... demonstrated need for high health care utilization. ...
(Date:7/10/2014)... Huddersfield could help to improve the quality of some ... as butter, mayonnaise, yoghurt and fruit drinks and ... her work. , Katerina gained her MSc degree in ... she has embarked on research for a PhD. ... investigating the potential of carbohydrates extracted from the pods ...
Breaking Medicine News(10 mins):Health News:Some Teens May Face Emotional Problems After Concussion 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 3Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 2Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 3Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3Health News:World interest in research work on the benefits of the Okra plant 2
... flying off the handle the next time someone cuts ... Yale School of Medicine researchers that links changes brought ... arrhythmias and sudden cardiac arrests, which are blamed for ... Lampert, M.D., associate professor of medicine at Yale School ...
... Feb. 24 Though the American Medical Association and ... funding of CME and though some big pharma companies ... even eliminating funding for CME by third-party vendors), 75 ... associations and teaching hospitals is funded by the bio-pharma ...
... from a baseball or hockey puck at just the right time could ... prevention were investigated in the March/April issue of Sports Health: A Multidisciplinary ... ... non-penetrating hit to the chest from a baseball or hockey puck at ...
... with the least education have a higher incidence of lung ... history accounts for approximately half of this risk, according to ... Journal of the National Cancer Institute. , Previous ... a higher risk for developing lung cancer. Some studies have ...
... chest pain are sent to a cardiologist to go through ... show no evidence of coronary artery disease which is the ... common occurrence in men, and these women are sent home ... their physicians complaining of similar symptoms and are more likely ...
... -- Ancient groundwater being tapped by Jordan, one of the ... to contain twenty times the radiation considered safe for drinking ... researchers. , "The combined activities of 228 radium and ... in the groundwater we tested are up to 2000 percent ...
Cached Medicine News:Health News:Educating the Market: Creating Value Through Support of Continuing Medical Education 2Health News:Study Shows Simple Measures May Help Prevent Sudden Death Event in Young Athletes 2Health News:Smoking behavior partially explains socioeconomic inequities in lung cancer incidence 2Health News:Cardiologists initiate STILETTO study to investigate treatment options for women with chest pain 2Health News:Jordan's fossil water source has high radiation levels 2Health News:Jordan's fossil water source has high radiation levels 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: